Inhalt
- Deutschsprachige Zeitschriften
- Englischsprachige Zeitschriften
- Deutschsprachige Bücher
- Englischsprachige Bücher
- Online Buch
- Gesamtverzeichnis Bücher
- Online Submission System
- Dustri TOC
- Dustri-Verlag
Benutzer Anmeldung
Geben Sie Ihren Benutzernamen und Ihr Passwort ein, um sich an der Webseite anzumelden:
Volume 48, No. 13/2010(Supplement 1)
|
|
|
| Preis für gesamte Ausgabe: 30.00$ |  |
Foreword
Ninth International Symposium on Lysosomal Storage Diseases
1
12$
Cellular mechanisms critical to lysosomal storage disease pathogenesis
Protein folding, oxidative stress, and the unfolded protein response
4
12$
Cellular mechanisms critical to lysosomal storage disease pathogenesis
Calcium homeostasis in lysosomal storage diseases
6
12$
Cellular mechanisms critical to lysosomal storage disease pathogenesis
Immune system irregularities in lysosomal storage diseases
8
12$
Cellular mechanisms critical to lysosomal storage disease pathogenesis
Lysosomal biogenesis, animal models and autophagy
10
8$
Cellular mechanisms critical to lysosomal storage disease pathogenesis
Diagnosis of mucolipidoses, rapid purification of lysosomal enzymes and intracellular localization studies using a novel mannose-6-phosphate-specific single-chain antibody
11
12$
Tools for the clinician
Orthopedic challenges in patients with mucopolysaccharidoses
14
12$
Tools for the clinician
Update on biomarkers for lysosomal sphingolipidoses
16
12$
Tools for the clinician
Newborn screening for lysosomal storage diseases
18
12$
Tools for the clinician
Achievement of therapeutic goals and severity scoring in Type 1 Gaucher disease
20
12$
Tools for the clinician
ARBs/ACE inhibitors in Fabry disease: rescue or peril?
22
12$
Tools for the clinician
Prevalence of kyphosis in patients with Type 1 and Type 3 Gaucher disease
24
12$
Tools for the clinician
Assessment of heart disease in lysosomal storage diseases
26
12$
Treatment strategies for metabolic leukodystrophies
Vulnerability of brain white matter in lysosomal storage diseases
29
12$
Treatment strategies for metabolic leukodystrophies
Therapies for the neuronal ceroid lipofuscinoses
31
12$
Treatment strategies for metabolic leukodystrophies
Combination therapy for globoid cell leukodystrophy
33
12$
Treatment strategies for metabolic leukodystrophies
Hematopoietic stem cell gene therapy for metachromatic leukodystrophy and other lysosomal storage diseases
35
12$
Neurological complications of lysosomal storage diseases
CNS imaging evaluation: toward the creation of a severity score
38
12$
Neurological complications of lysosomal storage diseases
The Sanfilippo syndromes: natural history
40
12$
Neurological complications of lysosomal storage diseases
Stroke in Fabry disease: complications and preventive strategies
42
12$
Plenary lectures
Membrane lipids and degenerative lysosomal storage diseases
45
12$
Plenary lectures
Charles Darwin and human society
47
8$
Selected posters: basic science, clinical research
In situ brain perfusion reveals functional changes in the blood-brain barrier in mouse models of Sanfilippo syndrome Types A and B
49
12$
Selected posters: basic science, clinical research
The Canadian Fabry Disease Initiative: a randomized controlled trial of agalsidase therapy in Fabry nephropathy
51
8$
Poster abstracts
Hunter syndrome, Fabry disease, Gaucher disease, Other mucopolysaccharide disorders, Other lysosomal storage diseases
53
100$
